Invitrogen Congratulates Winners of Nobel Prize in Chemistry
October 8, 2008
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today congratulates the three winners of the 2008 Nobel Prize in chemistry: Drs. Roger Tsien, Osamu Shimomura and Martin Chalfie, all of whom contributed to developing and expanding the use of fluorescent proteins in biological applications. Fluorescent proteins, including those [...]
October 8, 2008
Tripos International, a leading provider of drug discovery informatics products and services, today announced a collaboration agreement with AstraZeneca to develop a new drug discovery workflow solution. The centerpiece of the collaboration effort will be the development of Tripos' new Muse(TM) de novo design product, which is targeted for commercial release in the fourth quarter [...]
Protein Linked to Spinal Muscular Atrophy Identified
October 8, 2008
LIBERTYVILLE, Ill. & CARLSBAD, Calif. & WOODRIDGE, Ill.--Families of Spinal Muscular Atrophy (FSMA, www.curesma.org), Invitrogen Corporation (NASDAQ:IVGN)(www.invitrogen.com), and deCODE chemistry & biostructures (www.decodechembio.com) announced today they have identified a protein that is a potential molecular target for the treatment of Spinal Muscular Atrophy (SMA). In its most severe form, SMA often leads to death in [...]
Pressure BioSciences, Inc. Provides Corporate Update
October 8, 2008
SOUTH EASTON, Mass., Oct. 8 -- Pressure BioSciences, Inc. (Nasdaq: PBIO) ("PBI") today provided an update on various corporate activities, including the presentation of favorable data generated by scientists at Amgen, Inc. on the Company's pressure cycling technology ("PCT"), the scheduled presentation by Dr. Paul Pevsner of the NYU School of Medicine on the use [...]
October 8, 2008
REYKJAVIK, Iceland, Oct 08, 2008 -- Enables women to understand whether they may benefit from more intensive screening, monitoring or preventive drug therapy deCODE genetics today announced the launch of deCODE BreastCancer(TM), a new tool for assessing risk of the common forms of breast cancer. For the first time, a woman concerned about breast cancer [...]
October 8, 2008
NEWCASTLE UPON TYNE, England, Oct 08, 2008 -- Nonlinear Dynamics Ltd, the world leading developer of analysis solutions for proteomics and biomarker discovery, has announced that Boston University's Cardiovascular Proteomics Center (CPC) Core Laboratory have chosen the Progenesis software range for their label free LC-MS and 2D data analyses. Progenesis LC-MS v1.1 offers users an [...]
Luminex Corporation Receives Clearance from Health Canada for xTAG(TM) Respiratory Viral Panel
October 8, 2008
Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it has received clearance from Health Canada for its xTAG(TM) Respiratory Viral Panel (RVP). xTAG RVP is a unique, groundbreaking test that, from one patient sample, simultaneously detects the 18 respiratory viruses and subtypes that are responsible for the majority of respiratory [...]
October 8, 2008
Tripos International, a leading provider of drug discovery informatics products and services, today announced a collaboration agreement with AstraZeneca to develop a new drug discovery workflow solution. The centerpiece of the collaboration effort will be the development of Tripos' new Muse(TM) de novo design product, which is targeted for commercial release in the fourth quarter [...]
Helicos Ships Genetic Analysis System To Stanford University
October 7, 2008
CAMBRIDGE, Mass.--Helicos BioSciences Corporation (NASDAQ:HLCS - News) today announced the shipment of a Helicos™ Genetic Analysis System to Stanford University for use in research. The unique ability of the Helicos Genetic Analysis System to obtain sequence information from individual DNA molecules couples unparalleled throughput and scalability with an unbiased view of DNA and RNA that [...]
Pharsight and InforSense Establish Strategic Partnership.
October 7, 2008
Pharsight Expands Global Presence Through InforSense Chinese Distributor, Companies to Collaborate On Use of Biomarkers in PK/PD Modeling MOUNTAIN VIEW, Calif., and LONDON, Oct 7, 2008 -- Pharsight Corporation, a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, and InforSense Ltd., the leading provider of next-generation business and scientific [...]
